Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)		6 Months Ended
		Jun. 30, 2018	Jun. 30, 2017
Cash flows from operating activities:
Net income (loss) attributable to common shareholders		$ 10,805,994	$ (2,528,124)
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments		163,471	178,699
Realized investment gains, net		(649,446)	(544,060)
Change in fair value of equity securities	[1]	(15,360,956)	0
Unrealized trading (gains) losses included in income		0	111,531
Realized trading (gains) losses included in income		0	(110,470)
Amortization of cost of insurance acquired		403,033	419,553
Depreciation		572,751	349,582
Net income (loss) attributable to noncontrolling interest		152,487	(95,602)
Charges for mortality and administration of universal life and annuity products		(3,304,604)	(3,324,867)
Interest credited to account balances		2,119,747	2,181,552
Change in accrued investment income		131,976	330,290
Change in reinsurance receivables		469,778	169,621
Change in policy liabilities and accruals		(658,483)	(321,400)
Change in income taxes receivable (payable)		6,177	(75,074)
Change in other assets and liabilities, net		6,438,057	(1,153,065)
Net cash provided by (used in) operating activities		1,289,982	(4,411,834)
Proceeds from investments sold and matured:
Fixed maturities available for sale		12,881,864	9,585,460
Equity securities		716,323	2,126,149
Mortgage loans		2,240,015	562,792
Real estate		9,472,966	5,083,776
Notes receivable		824,062	305,874
Policy loans		1,087,790	1,087,870
Short term investment		2,114,000	0
Total proceeds from investments sold and matured		29,337,020	18,751,921
Cost of investments acquired:
Fixed maturities available for sale		(15,304,506)	(7,141,692)
Equity securities		(9,010,290)	(2,424,875)
Mortgage loans		0	(354,306)
Real estate		(8,420,117)	(1,678,891)
Notes receivable		(4,000,000)	(2,047,853)
Policy loans		(960,620)	(782,464)
Short-term investments		(2,114,000)	0
Total cost of investments acquired		(39,809,533)	(14,430,081)
Net cash provided by (used in) investing activities		(10,472,513)	4,321,840
Cash flows from financing activities:
Policyholder contract deposits		2,426,333	2,470,129
Policyholder contract withdrawals		(3,569,583)	(2,838,813)
Payments of principal on notes payable/line of credit		0	(1,450,000)
Purchase of treasury stock		(953,419)	(206,178)
Issuance of stock		246,757	197,486
Non controlling contributions (distributions) of consolidated subsidiary		(247,592)	(732,752)
Net cash provided by (used in) financing activities		(2,097,504)	(2,560,128)
Net increase (decrease) in cash and cash equivalents		(11,280,035)	(2,650,122)
Cash and cash equivalents at beginning of period		25,434,199	15,156,548
Cash and cash equivalents at end of period		$ 14,154,164	$ 12,506,426

[1] Effective January 1, 2018, the Company adopted ASU No. 2016-01. As a result, equity securities are no longer classified as available-for-sale with unrealized gains and losses recognized in other comprehensive income; rather, all changes in the fair value of equity securities are now recognized in net income. Prior periods have not been restated to conform to the current presentation. See note 2.